Liraglutide (Victoza)


Indications

Type 2 Diabetes Mellitus (NIDDM) (see Diabetes Mellitus)


Pharmacology

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist (see Glucagon-Like Peptide-1 Receptor Agonists)


Administration


Adverse Effects

Other Adverse Effects


References